Success Metrics

Clinical Success Rate
88.6%

Based on 178 completed trials

Completion Rate
89%(178/201)
Active Trials
89(22%)
Results Posted
11%(19 trials)
Terminated
23(6%)

Phase Distribution

Ph phase_3
31
8%
Ph phase_4
2
1%
Ph early_phase_1
2
1%
Ph not_applicable
39
10%
Ph phase_1
2
1%
Ph phase_2
26
7%

Phase Distribution

4

Early Stage

26

Mid Stage

33

Late Stage

Phase Distribution102 total trials
Early Phase 1First-in-human
2(2.0%)
Phase 1Safety & dosage
2(2.0%)
Phase 2Efficacy & side effects
26(25.5%)
Phase 3Large-scale testing
31(30.4%)
Phase 4Post-market surveillance
2(2.0%)
N/ANon-phased studies
39(38.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

86.8%

178 of 205 finished

Non-Completion Rate

13.2%

27 ended early

Currently Active

89

trials recruiting

Total Trials

396

all time

Status Distribution
Active(116)
Completed(178)
Terminated(27)
Other(75)

Detailed Status

Completed178
unknown73
Recruiting71
Terminated23
Not yet recruiting23
Active, not recruiting18

Development Timeline

Analytics

Development Status

Total Trials
396
Active
89
Success Rate
88.6%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (2.0%)
Phase 12 (2.0%)
Phase 226 (25.5%)
Phase 331 (30.4%)
Phase 42 (2.0%)
N/A39 (38.2%)

Trials by Status

terminated236%
suspended21%
enrolling_by_invitation41%
not_yet_recruiting236%
recruiting7118%
completed17845%
unknown7318%
withdrawn41%
active_not_recruiting185%

Recent Activity

Clinical Trials (396)

Showing 20 of 396 trialsScroll for more
NCT07533890Not Applicable

Fecal Microbiome Signature of Multi-Strain Probiotics Supplementation in Children and Adolescents With Inflammatory Bowel Disease

Not Yet Recruiting
NCT05640999Phase 2

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

Recruiting
NCT06663163

The Association Between Fever and CDKL5 Deficiency Disorder: a Nationwide Survey

Completed
NCT03503799

Reaching for Evidence-baSed Chemotherapy Use in Endocrine Sensitive Breast Cancer

Active Not Recruiting
NCT01244789Phase 2

Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer

Active Not Recruiting
NCT05976347Phase 4

Identifying and Treating Depression in the Orthopaedic Trauma Population

Recruiting
NCT05257551

TEMPUS Small Cell Lung Cancer OBSERVATIONAL STUDY (Sculptor)

Recruiting
NCT05601440Phase 2

Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer

Recruiting
NCT07487480

A Prospective Observational Study on the Efficacy and Safety of Guselkumab in the Treatment of Crohn's Disease Patients Previously Treated With Ustekinumab

Recruiting
NCT06817408

Dynamics of Organ Damage and Immune Exhaustion During Sepsis

Recruiting
NCT07472478Phase 2

Phase II Neoadjuvant Study of Garsorasib Followed by Ivonescimab Plus Chemotherapy in Resectable Stage IIA-IIIB KRAS G12C-Mutant NSCLC (GIVEN Study)

Not Yet Recruiting
NCT06249880

Pediatric Normative Markerless Movement Analysis

Recruiting
NCT07457099

Impact of Postoperative Radiotherapy Versus PD-1 Inhibitor Maintenance on Survival in Resectable Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma

Not Yet Recruiting
NCT00448448Not Applicable

Bracing in Adolescent Idiopathic Scoliosis Trial (BrAIST)

Terminated
NCT07438288

Predictors of Decompensation, Acute-on-chronic Liver Failure and Mortality in Liver Cirrhosis

Recruiting
NCT00003641Phase 3

High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma

Active Not Recruiting
NCT06378346Phase 2

GU-01: Glycyrrhizin in Prostate Cancer

Recruiting
NCT07415603

PPV vs PVI in the Supine and Prone Position

Not Yet Recruiting
NCT07413211

Genetic Developmental and Epileptic Encephalopathy Natural History Study for Clinical Trial Readiness

Recruiting
NCT07410247

MPN Childhood Registry

Recruiting

Drug Details

Intervention Type
OTHER
Total Trials
396